(TRN) Trinity Industries - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8965221091
Stock:
Total Rating 46
Risk 41
Buy Signal 0.20
| Risk 5d forecast | |
|---|---|
| Volatility | 34.5% |
| Relative Tail Risk | -9.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | -1.40 |
| Character TTM | |
|---|---|
| Beta | 1.023 |
| Beta Downside | 1.299 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.58% |
| CAGR/Max DD | 0.30 |
EPS (Earnings per Share)
Revenue
Description: TRN Trinity Industries
Trinity Industries, Inc. provides railcar products and services under the TrinityRail trade name in North America. The company operates in two segments, Railcar Leasing and Services Group, and Rail Products Group. The Railcar Leasing and Services Group segment leases freight and tank railcars; originates and manages railcar leases for third-party investors; and provides fleet leasing, management, and administrative services, as well as railcar maintenance and modification services, and other railcar logistics products and services. As of December 31, 2025, it had a fleet of 101,485 railcars. This segment serves industrial shipper and railroad companies operating in refined products and chemicals, energy, agriculture, construction and metals, and consumer products. The Rail Products Group segment manufactures freight and tank railcars for transporting various liquids, gases, and dry cargo; and manufactures and sells railcars and related parts and components. This segment serves railroads, leasing companies, and industrial shippers of products in the refined products and chemicals, energy, agriculture, construction and metals, and consumer products markets. It sells or leases products and services through its own sales personnel and independent sales representatives. The company was incorporated in 1933 and is headquartered in Dallas, Texas.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 253.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA -4.92 > 1.0 |
| NWC/Revenue: 22.66% < 20% (prev -6.91%; Δ 29.57% < -1%) |
| CFO/TA 0.04 > 3% & CFO 359.7m > Net Income 253.1m |
| Net Debt (5.24b) to EBITDA (628.3m): 8.34 < 3 |
| Current Ratio: 1.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (81.8m) vs 12m ago -2.85% < -2% |
| Gross Margin: 26.55% > 18% (prev 0.22%; Δ 2634 % > 0.5%) |
| Asset Turnover: 25.00% > 50% (prev 34.86%; Δ -9.87% > 0%) |
| Interest Coverage Ratio: 1.46 > 6 (EBITDA TTM 628.3m / Interest Expense TTM 274.2m) |
Altman Z'' 1.24
| A: 0.06 (Total Current Assets 1.06b - Total Current Liabilities 570.8m) / Total Assets 8.42b |
| B: 0.12 (Retained Earnings 1.02b / Total Assets 8.42b) |
| C: 0.05 (EBIT TTM 400.2m / Avg Total Assets 8.63b) |
| D: 0.15 (Book Value of Equity 1.08b / Total Liabilities 7.28b) |
| Altman-Z'' Score: 1.24 = BB |
Beneish M 1.00
| DSRI: 1.56 (Receivables 416.6m/381.5m, Revenue 2.16b/3.08b) |
| GMI: 0.81 (GM 26.55% / 21.55%) |
| AQI: 14.25 (AQ_t 0.83 / AQ_t-1 0.06) |
| SGI: 0.70 (Revenue 2.16b / 3.08b) |
| TATA: -0.01 (NI 253.1m - CFO 359.7m) / TA 8.42b) |
| Beneish M-Score: 4.89 (Cap -4..+1) = D |
What is the price of TRN shares?
As of February 27, 2026, the stock is trading at USD 34.22 with a total of 424,563 shares traded.
Over the past week, the price has changed by +0.20%, over one month by +21.78%, over three months by +30.74% and over the past year by +14.84%.
Over the past week, the price has changed by +0.20%, over one month by +21.78%, over three months by +30.74% and over the past year by +14.84%.
Is TRN a buy, sell or hold?
Trinity Industries has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold TRN.
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.5 | -2.1% |
| Analysts Target Price | 33.5 | -2.1% |
TRN Fundamental Data Overview February 24, 2026
P/E Trailing = 11.1369
P/E Forward = 20.0803
P/S = 1.3106
P/B = 2.2246
P/EG = 2.78
Revenue TTM = 2.16b USD
EBIT TTM = 400.2m USD
EBITDA TTM = 628.3m USD
Long Term Debt = 5.94b USD (from longTermDebt, two quarters ago)
Short Term Debt = 17.8m USD (from shortTermDebt, two quarters ago)
Debt = 5.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.24b USD (from netDebt column, last quarter)
Enterprise Value = 8.07b USD (2.83b + Debt 5.44b - CCE 201.3m)
Interest Coverage Ratio = 1.46 (Ebit TTM 400.2m / Interest Expense TTM 274.2m)
EV/FCF = -18.54x (Enterprise Value 8.07b / FCF TTM -435.2m)
FCF Yield = -5.39% (FCF TTM -435.2m / Enterprise Value 8.07b)
FCF Margin = -20.18% (FCF TTM -435.2m / Revenue TTM 2.16b)
Net Margin = 11.73% (Net Income TTM 253.1m / Revenue TTM 2.16b)
Gross Margin = 26.55% ((Revenue TTM 2.16b - Cost of Revenue TTM 1.58b) / Revenue TTM)
Gross Margin QoQ = 25.47% (prev 31.14%)
Tobins Q-Ratio = 0.96 (Enterprise Value 8.07b / Total Assets 8.42b)
Interest Expense / Debt = 1.30% (Interest Expense 70.6m / Debt 5.44b)
Taxrate = 25.79% (68.3m / 264.8m)
NOPAT = 297.0m (EBIT 400.2m * (1 - 25.79%))
Current Ratio = 1.86 (Total Current Assets 1.06b / Total Current Liabilities 570.8m)
Debt / Equity = 5.05 (Debt 5.44b / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 8.34 (Net Debt 5.24b / EBITDA 628.3m)
Debt / FCF = -12.04 (negative FCF - burning cash) (Net Debt 5.24b / FCF TTM -435.2m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.93% (Net Income 253.1m / Total Assets 8.42b)
RoE = 24.45% (Net Income TTM 253.1m / Total Stockholder Equity 1.04b)
RoCE = 5.73% (EBIT 400.2m / Capital Employed (Equity 1.04b + L.T.Debt 5.94b))
RoIC = 4.35% (NOPAT 297.0m / Invested Capital 6.83b)
WACC = 3.94% (E(2.83b)/V(8.27b) * Re(9.68%) + D(5.44b)/V(8.27b) * Rd(1.30%) * (1-Tc(0.26)))
Discount Rate = 9.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.02%
[DCF] Fair Price = unknown (Cash Flow -435.2m)
EPS Correlation: 60.14 | EPS CAGR: 218.5% | SUE: 4.0 | # QB: 1
Revenue Correlation: 16.96 | Revenue CAGR: 7.09% | SUE: 0.60 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.27 | Chg7d=-0.045 | Chg30d=-0.045 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.93 | Chg7d=+0.275 | Chg30d=+0.325 | Revisions Net=+1 | Growth EPS=-38.7% | Growth Revenue=+0.9%
EPS next Year (2027-12-31): EPS=2.20 | Chg7d=+0.275 | Chg30d=+0.200 | Revisions Net=+1 | Growth EPS=+14.3% | Growth Revenue=+15.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 9.7% - Earnings Yield 9.0%)
[Growth] Growth Spread = -10.5% (Analyst -9.8% - Implied 0.7%)
P/E Forward = 20.0803
P/S = 1.3106
P/B = 2.2246
P/EG = 2.78
Revenue TTM = 2.16b USD
EBIT TTM = 400.2m USD
EBITDA TTM = 628.3m USD
Long Term Debt = 5.94b USD (from longTermDebt, two quarters ago)
Short Term Debt = 17.8m USD (from shortTermDebt, two quarters ago)
Debt = 5.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.24b USD (from netDebt column, last quarter)
Enterprise Value = 8.07b USD (2.83b + Debt 5.44b - CCE 201.3m)
Interest Coverage Ratio = 1.46 (Ebit TTM 400.2m / Interest Expense TTM 274.2m)
EV/FCF = -18.54x (Enterprise Value 8.07b / FCF TTM -435.2m)
FCF Yield = -5.39% (FCF TTM -435.2m / Enterprise Value 8.07b)
FCF Margin = -20.18% (FCF TTM -435.2m / Revenue TTM 2.16b)
Net Margin = 11.73% (Net Income TTM 253.1m / Revenue TTM 2.16b)
Gross Margin = 26.55% ((Revenue TTM 2.16b - Cost of Revenue TTM 1.58b) / Revenue TTM)
Gross Margin QoQ = 25.47% (prev 31.14%)
Tobins Q-Ratio = 0.96 (Enterprise Value 8.07b / Total Assets 8.42b)
Interest Expense / Debt = 1.30% (Interest Expense 70.6m / Debt 5.44b)
Taxrate = 25.79% (68.3m / 264.8m)
NOPAT = 297.0m (EBIT 400.2m * (1 - 25.79%))
Current Ratio = 1.86 (Total Current Assets 1.06b / Total Current Liabilities 570.8m)
Debt / Equity = 5.05 (Debt 5.44b / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 8.34 (Net Debt 5.24b / EBITDA 628.3m)
Debt / FCF = -12.04 (negative FCF - burning cash) (Net Debt 5.24b / FCF TTM -435.2m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.93% (Net Income 253.1m / Total Assets 8.42b)
RoE = 24.45% (Net Income TTM 253.1m / Total Stockholder Equity 1.04b)
RoCE = 5.73% (EBIT 400.2m / Capital Employed (Equity 1.04b + L.T.Debt 5.94b))
RoIC = 4.35% (NOPAT 297.0m / Invested Capital 6.83b)
WACC = 3.94% (E(2.83b)/V(8.27b) * Re(9.68%) + D(5.44b)/V(8.27b) * Rd(1.30%) * (1-Tc(0.26)))
Discount Rate = 9.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.02%
[DCF] Fair Price = unknown (Cash Flow -435.2m)
EPS Correlation: 60.14 | EPS CAGR: 218.5% | SUE: 4.0 | # QB: 1
Revenue Correlation: 16.96 | Revenue CAGR: 7.09% | SUE: 0.60 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.27 | Chg7d=-0.045 | Chg30d=-0.045 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=1.93 | Chg7d=+0.275 | Chg30d=+0.325 | Revisions Net=+1 | Growth EPS=-38.7% | Growth Revenue=+0.9%
EPS next Year (2027-12-31): EPS=2.20 | Chg7d=+0.275 | Chg30d=+0.200 | Revisions Net=+1 | Growth EPS=+14.3% | Growth Revenue=+15.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 9.7% - Earnings Yield 9.0%)
[Growth] Growth Spread = -10.5% (Analyst -9.8% - Implied 0.7%)